Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. Feb 2009 - Clin. Vaccine Immunol.; 16(2):1556-679X [PMID:19038780] [Whiteside TL] [Piazza P] [Reiter A] [Stanson J] [Connolly NC] [Rinaldo CR] [Riddler SA]
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Feb 2008 - Clin. Vaccine Immunol.; 15(2):1556-679X [PMID:17942609] [Connolly NC] [Whiteside TL] [Wilson C] [Kondragunta V] [Rinaldo CR] [Riddler SA]
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects. Aug 2007 - AIDS; 21(13):0269-9370 [PMID:17690565] [Connolly N] [Riddler S] [Stanson J] [Gooding W] [Rinaldo CR] [Ferrone S] [Whiteside TL]
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. Feb 2005 - J. Virol.; 79(5):0022-538X [PMID:15709025] [Huang XL] [Fan Z] [Colleton BA] [Buchli R] [Li H] [Hildebrand WH] [Rinaldo CR]
Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells. Feb 2002 - J. Virol.; 76(6):0022-538X [PMID:11861866] [Zhao XQ] [Huang XL] [Gupta P] [Borowski L] [Fan Z] [Watkins SC] [Thomas EK] [Rinaldo CR]
